blur de-identification
TRANSCRIPT
© d-Wise 2015 Page ‹#›
d-WiseDe-Identification and Anonymization
empowering innovation for a healthier world
© d-Wise 2015 Page ‹#›
d-Wise
Put people in the center of the picture
Define actionable solutions
Achieve success
through small steps
Manage change &
expect to adapt
We are a global technology consulting firm focused on simplifying the life sciences enterprise
Life Science Clients Partners
© d-Wise 2015 Page ‹#›
Our Services
Helping clients navigate standards adoption• CDISC Standards• Standards Governance• People, process, and
technology• Development, Use and
Maintenance
StandardsEnabling the business by
leveraging technology• MDR, CDR, EDC, SCE• System Integration• Industry Product
Development• Custom Development• Technology selection and
implementation
TechnologyAligning strategy and
execution for success• Gap Analysis• Process Optimization• Organizational Design• SOP Development• Matching processes to
organizational goals
Process
EXECUTION | PROGRAM & PROJECT MANAGEMENT | ORGANIZATIONAL CHANGE
STRATEGY | ADVISORY | IMPLEMENTATION
© d-Wise 2015 Page ‹#›
The d-Wise De-Identification Solution
Blur is the industry-leading solution for delivering de-identified clinical trial data
and protecting patient privacy
“As we expand the availability and sharing of our patient-level clinical trial data to support the improvement of healthcare, we decided to streamline
our processes further. d-Wise’s software solution will help us to achieve this in a way that continues to safeguard the quality of the data.”
James Armbrust, AstraZeneca Head, Clinical Trial Transparency & Disclosure
© d-Wise 2015 Page ‹#›
Challenges of Patient-Level Data De-Identification
Historically, de-identification has been a low volume, low visibility process– Minimally maintained tools– Drop-in resourcing– Low priority work– No automation
Growing interest in sharing de-identified data internally and externally is stressing existing processes
Public sensitivity to privacy has never been higher
© d-Wise 2015 Page ‹#›
The Value of d-Wise Blur
Reduced de-id costs• 90%
reduction for standardized data
• 70% reduction for other trials
• Decreased outsourcing
Designed for clinical trials• Underst
ands CDISC, SAS and other data types
• Supports PhUSE and emerging rules
• Integrated workflow controls process
• Audit trail captures data activities
Reduced IT costs • Internal
development is time-consuming
• SAS Macro maintenance is challenging
• COTS application enables industry alignment
© d-Wise 2015 Page ‹#›
Blur CapabilitiesApplication-Driven with Zero Coding
Integrated Workflow and Controls
Rapid Replication Across Projects
Designed for clinical trials
© d-Wise 2015 Page ‹#›
There is tremendous growth in the need to de-identify clinical trial data
Existing tools and approaches are too time-consuming, too labor-intensive and too costly
Blur will enable you to deliver high-quality de-identified clinical trial data to your internal and external
collaborators at lower cost and with faster turnaround time than any other approach available today.